CompanyScope

Merck & Co., Inc. (MRK)

Ticker MRK · SEC CIK 310158 · Latest fiscal year ended Dec 31, 2025

Merck & Co., Inc. reported revenue of $65.01B for the fiscal year ended Dec 31, 2025, up 1.3% from $64.17B the year before. Net income was $18.25B, a net margin of 28.1% (prior year: $17.12B). At the end of that fiscal year the company reported total assets of $136.87B and shareholders' equity of $52.61B.

Revenue
$65.01B
+1.3% vs prior year
Net income
$18.25B
Net margin 28.1%
Diluted EPS
$7.28
USD per share
Total assets
$136.87B
At Dec 31, 2025
Equity
$52.61B
At Dec 31, 2025
Shares outstanding
2,467M
As of Jul 31, 2026
$0$20B$40B$60B$80BDec 2016: $39.81BDec 2017: $40.12BDec 2018: $42.29BDec 2019: $39.12BDec 2020: $41.52BDec 2021: $48.70BDec 2022: $59.28BDec 2023: $60.12BDec 2024: $64.17BDec 2025: $65.01BDec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Merck & Co., Inc. annual revenue, USD. Hover a bar for the exact figure.

Explore Merck & Co., Inc.'s filings

Latest SEC filings

Compare Merck & Co., Inc.

Source: SEC EDGAR XBRL company facts for CIK 310158 (raw data). Most recent filing in this dataset: 10-Q filed Aug 7, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.